Pharmacogenetics of taxane‐induced neurotoxicity in breast cancer: Systematic review and meta‐analysis
Abstract Taxane‐based chemotherapy regimens are used as first‐line treatment for breast cancer. Neurotoxicity, mainly taxane‐induced peripheral neuropathy (TIPN), remains the most important dose‐limiting adverse event. Multiple genes may be associated with TIPN; however, the strength and direction o...
Saved in:
Main Authors: | Alberto Guijosa (Author), Ana Freyria (Author), Jose Rodrigo Espinosa‐Fernandez (Author), Francisco J. Estrada‐Mena (Author), Ana Sofía Armenta‐Quiroga (Author), Maria Fernanda Ortega‐Treviño (Author), Rodrigo Catalán (Author), Bani Antonio‐Aguirre (Author), Cynthia Villarreal‐Garza (Author), Andric C. Perez‐Ortiz (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neoadjuvant chemotherapy outcome with taxane-based versus non-taxane protocols in gastric cancer
by: Shirin Kianersi, et al.
Published: (2023) -
Cell death in cancer chemotherapy using taxanes
by: Ana P. Xu, et al.
Published: (2024) -
Taxanes in adjuvant and neoadjuvant therapy for breast cancer
by: S. V. Limareva
Published: (2014) -
Supplemental Preparations in Taxane-Induced Neuropathy Management
by: AmirHosein Sanei, et al.
Published: (2023) -
Impact of taxane-based chemotherapeutics on male reproductive function
by: Charvi Kanodia, et al.
Published: (2023)